Align with our findings of EpCAM CAR in vivo, it has been reported that trophoblast cell surface antigen 2 (Trop2) targeting CAR-T cells injected intravenously could inhibit pancreatic tumor growth in the same BxPC-3 xenograft model [47]. Here, TACSTD2 is linked to pancreatic neoplasm.